https://scholars.lib.ntu.edu.tw/handle/123456789/577176
標題: | Nanoparticle-hydrogel composite drug delivery system for potential ocular applications | 作者: | Hsu X.-L Wu L.-C Hsieh J.-Y Huang Y.-Y. YI-YOU HUANG |
關鍵字: | Biochemistry; Biocompatibility; Diseases; Drug products; Hyaluronic acid; Hydrogels; Mammals; Nanoparticles; Ophthalmology; Physiological models; Proteins; Swelling; Targeted drug delivery; Age-related macular degeneration; Anti-vascular endothelial growth factors; Bovine serum albumins; Drug delivery system; Drug-loading efficiency; Hyaluronan hydrogels; Intravitreal injection; Physiological condition; Controlled drug delivery | 公開日期: | 2021 | 卷: | 13 | 期: | 4 | 起(迄)頁: | 1-19 | 來源出版物: | Polymers | 摘要: | Intravitreal injections are clinically established procedures in the treatment of posterior eye diseases, such as wet age-related macular degeneration (wet AMD) which requires monthly intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) protein drugs that can lead to complications due to frequent dosing. In this study, we designed a composite drug delivery system (DDS) consisting of drug-loaded poly (lactide–co–glycolide) (PLGA) nanoparticles and a chemically crosslinked hyaluronan hydrogel to reduce the dosing frequency. The morphology, size, composition, and drug loading efficiency of the prepared nanoparticles were characterized. The properties of the modified hyaluronan polymers used were also examined. The degree of swelling/degradation and controlled release ability of the hyaluronan hydrogel and the composite DDS were identified using bovine serum albumin (BSA) as a model drug. The results show that this system can retain 75% of its wet weight without losing its integrity and release the model drug at the rate of 0.4 ?g/day for more than two months under physiological conditions. In addition, the nanoparticulate formulation of the system can further improve bioavailability of the drugs by penetrating deep into the retinal layers. In conclusion, the proposed composite DDS is easily prepared with biocompatible materials and is promising for providing the sustained release of the protein drugs as a better treatment for ocular neovascular diseases like wet AMD. ? 2021 by the authors. Licensee MDPI, Basel, Switzerland. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101858355&doi=10.3390%2fpolym13040642&partnerID=40&md5=15f9176123b9c3ec19048c0ff3fea532 https://scholars.lib.ntu.edu.tw/handle/123456789/577176 |
ISSN: | 20734360 | DOI: | 10.3390/polym13040642 |
顯示於: | 醫學工程學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。